Andrea Kay
- Pulmonary and Respiratory Medicine top 0.2%
- Molecular Biology top 2%
- Oncology top 0.5%
- Cancer Research top 0.5%
- Physiology top 5%
- Co-authors
- Bernard EscudierRobert J. MotzerAlain RavaudNorbert HollaenderThomas E. HutsonSergio BracardaCamillo PortaStéphane Oudard
- Topics
- Renal cell carcinoma treatment (16 papers)Cancer Genomics and Diagnostics (10 papers)Renal and related cancers (6 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Andrea Kay
46 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Pulmonary and Respiratory Medicine 4.7k
- Molecular Biology 3.7k
- Oncology 3.2k
- Cancer Research 1.8k
- Physiology 758
Countries citing papers authored by Andrea Kay
This map shows the geographic impact of Andrea Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Kay more than expected).
Fields of papers citing papers by Andrea Kay
This network shows the impact of papers produced by Andrea Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Kay. The network helps show where Andrea Kay may publish in the future.
Co-authorship network of co-authors of Andrea Kay
This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Kay. A scholar is included among the top collaborators of Andrea Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Kay. Andrea Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 251 | |
| 2 | 103 | |
| 3 | 49 | |
| 4 | 2 | |
| 5 | 156 | |
| 6 | Phase 3 trial of everolimus for metastatic renal cell carcinomabreakdown → | 903 |
| 7 | 188 | |
| 8 | 42 | |
| 9 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialbreakdown → | 2339 |
| 10 | 42 | |
| 11 | 5 | |
| 12 | 15 | |
| 13 | 12 | |
| 14 | 149 | |
| 15 | 105 | |
| 16 | 13 | |
| 17 | 17 | |
| 18 | 138 | |
| 19 | 79 | |
| 20 | 5 |
About Andrea Kay
Andrea Kay is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 46 papers that have together received 7.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Cancer Genomics and Diagnostics (10 papers) and Renal and related cancers (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Cancer Research (1.8k citations) and Oncology (3.2k citations). Andrea Kay has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Bernard Escudier, Robert J. Motzer, Alain Ravaud, Norbert Hollaender, Thomas E. Hutson, Sergio Bracarda, Camillo Porta, Stéphane Oudard, Robert A. Figlin and John A. Thompson. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.